• Home>
  • Stocks>
  • Strides Pharma Science Ltd Share Price
bell
The current prices are delayed by 15 mins, login to check live prices.
Strides Pharma Science Ltd share price logo

Strides Pharma Science Ltd Share Price

(STAR)

₹688.43.77%

as on 04:01PM, 04 Feb 2025

Overview
News
Financials
Q3 FY24-25 Results
Technicals

Strides Pharma Science Ltd Analyst Rating

based on 3 analysts

BUY

66.67%

Buy

0.00%

Hold

33.33%

Sell

Based on 3 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1373

Source: S&P Global Market Intelligence

Strides Pharma Science Ltd Share analysis

Strides Pharma Science Ltd price forecast by 3 analysts

Upside of106.96%

High

₹1874

Target

₹1373.00

Low

₹1070

Strides Pharma Science Ltd target price ₹1373, a slight upside of 106.96% compared to current price of ₹688.4. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Strides Pharma Science Ltd Performance

  • Day's Low

    Day's High

    ₹669
    Day's Price Range
    ₹708.7
  • 52 Week's Low

    52 Week's High

    ₹530
    52-Week Price Range
    ₹1,675
1 Month Return-3.27 %
3 Month Return-57.5 %
1 Year Return-4.52 %
Previous Close₹663.40
Open₹670.00
Volume7.40L
Upper Circuit-
Lower Circuit-
Market Cap₹6,114.07Cr

Strides Pharma Science Ltd Key Statistics

P/E Ratio38.57
PEG Ratio1.75
Market Cap₹6,114.07 Cr
P/B Ratio2.02
EPS-4.49599698514042
Dividend Yield0.32
SectorPharmaceuticals
ROE1.87

Strides Pharma Science Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹6,114.07 Cr7.48%0.66-₹95 Cr₹4,051 Cr
BUY₹14,414.15 Cr11.43%0.51NANA
NA₹5,045.34 Cr-3%0.79-₹388 Cr₹75 Cr
NA₹547.12 Cr-3.49%0.54NANA
NA₹64.67 Cr-2.32%0.57NANA

About Strides Pharma Science Ltd

Strides Pharma Science Ltd is an integrated pharmaceutical company listed on the Indian stock exchange. They are focused on developing, manufacturing and marketing pharmaceutical products in India and overseas. With a strong presence in regulated and semi-regulated markets, they offer a wide array of products ranging from Tablets, Capsules, Powders and Oral Liquids to Ointments, Softgel Capsules and Injectables. Their portfolio of services includes Product Development, Contract Manufacturing, Regulatory and Quality Compliance Support and Supply Chain Solutions. Their commitment to quality and innovation, along with the ability to serve their clients with a reliable, cost-effective and timely product supply, has helped them gain a foothold in the pharmaceutical industry. With their focus on meeting the ever-changing needs of customers, Strides Pharma Science Ltd is uniquely positioned in the pharmaceutical landscape.

Share Price: ₹688.40 per share as on 04 Feb, 2025 04:01 PM
Market Capitalisation: ₹6,114.07Cr as of today
Revenue: ₹1,153.67Cr as on December 2024 (Q4 24)
Net Profit: ₹90.04Cr as on December 2024 (Q4 24)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
OrganisationStrides Pharma Science Ltd
HeadquartersBangaluru
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Strides Pharma Science Ltd

  • Strides Pharma Announces Leadership Transition - 31 Jan, 2025

    Strides Pharma Science has announced that Arun Kumar will transition from Executive Chairperson to Non-Executive Chairperson effective April 5, 2025, following the appointment of Badree Komandur as Managing Director and Group CEO.
  • Strides Pharma Reports Strong Q3 FY25 Results - 30 Jan, 2025

    Strides Pharma Science Ltd. announced robust Q3 FY25 results, with a 15% revenue increase to ₹1,154 crore and a net profit surge to ₹90 crore, recovering from a loss last year. The company emphasizes operational efficiencies and positive growth outlook.
  • Strides Pharma Reports Q2FY25 Revenue and Profit - 27 Jan, 2025

    Strides Pharma Science Limited reported a revenue of Rs. 1,201 crore and a net profit of Rs. 94 crore for Q2FY25. However, shares declined by 8.04% to Rs. 557.90.
  • Strides Pharma Shares Surge Ahead of OneSource Listing - 23 Jan, 2025

    Strides Pharma Science shares surged nearly 10% as OneSource Specialty Pharma received approval for listing on NSE and BSE, starting January 24, 2025. The company reported a significant turnaround in Q2 FY25 with a net profit of Rs 93.7 crore, up from a loss last year, driven by strong U.S. performance.
  • Strides Pharma Secures USFDA Approval for Pain Relief - 20 Jan, 2025

    Strides Pharma Science Ltd. announced USFDA approval for its Acetaminophen and Ibuprofen over-the-counter tablets, strengthening its OTC product offerings and catering to a broader patient base.

Insights on Strides Pharma Science Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.80% to 10.86% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.83% to 27.77% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, STAR stock has moved up by 15.8%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 25.84% to 26.82% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 18.18 Cr → 87.95 Cr (in ₹), with an average increase of 31.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 59.1% return, outperforming this stock by 63.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.2% return, outperforming this stock by 72.0%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 30.08% to 28.48% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.19K Cr → 1.16K Cr (in ₹), with an average decrease of 2.9% per quarter

Strides Pharma Science Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,005.77Cr (-)₹1,084.04Cr (↑7.78%)₹1,087.51Cr (↑0.32%)₹1,166.93Cr (↑7.30%)₹1,153.67Cr (↓1.14%)
Net Income₹54.06Cr (-)₹10.44Cr (↓80.69%)₹68.31Cr (↑554.31%)₹72.27Cr (↑5.80%)₹90.04Cr (↑24.59%)
Net Profit Margin5.37% (-)0.96% (↓82.12%)6.28% (↑554.17%)6.19% (↓1.43%)7.80% (↑26.01%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,264.26Cr (-)₹5,478.46Cr (↑4.07%)₹5,658.16Cr (↑3.28%)₹5,871.07Cr (↑3.76%)
Total Liabilities₹2,016.20Cr (-)₹2,071.77Cr (↑2.76%)₹2,203.11Cr (↑6.34%)₹2,309.95Cr (↑4.85%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹137.64Cr (-)₹282.76Cr (↑105.43%)-₹282.69Cr (↓199.98%)₹241.74Cr (↓185.51%)-₹35.76Cr (↓114.79%)

Index Inclusions

BSE Healthcare

₹42,560.75

1.59 (664.21%)

BSE Small-Cap

₹49,801.07

1.2 (588.77%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Strides Pharma Science Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
26.82%
3.81
Foreign Institutions
28.48%
-5.31
Mutual Funds
10.86%
0.57
Retail Investors
27.77%
7.48
Others
6.07%
-18.55

Strides Pharma Science Ltd Key Indicators

Details20202021202220232024
Return On Assets %0.775.1-8.4-3.58-1.2
Details20202021202220232024
Book Value Per Share (₹)123.65135.68115.12106.52101.35
Details20202021202220232024
Earning Per Share (₹)1.512.59-23.15-10.3-4.5
Details20202021202220232024
Return On Equity %3.752.445.290.611.87

Strides Pharma Science Ltd Valuation

Strides Pharma Science Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-409.06x)

July 5, 2021

Today (38.57x)

February 3, 2025

Industry (53.65x)

February 3, 2025

Highest (6306.63x)

September 27, 2024

LowHigh

Strides Pharma Science Ltd Earnings and Dividends

  • Strides Pharma Science Ltd Earnings Results

    Strides Pharma Science Ltd’s net profit jumped 77.07% since last year same period to ₹87.95Cr in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 22.42% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Strides Pharma Science Ltd Dividends May,2024

    In the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.58%.

    Read More about Dividends

Strides Pharma Science Ltd Technicals Summary

Bearish

Neutral

Bullish

Neutral

Strides Pharma Science Ltd is currently in a Neutral trading position according to technical analysis indicators.

FAQs on Strides Pharma Science Ltd

What is Strides Pharma Science Ltd price today?

Strides Pharma Science Ltd share price today stands at ₹688.4, Open: ₹670, Previous Close: ₹663.4, High: ₹708.7, Low: ₹669, 52 Week High: ₹1675, 52 Week Low: ₹530.

How to Buy Strides Pharma Science Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Strides Pharma Science Ltd shares

Is Strides Pharma Science Ltd listed on NSE?

Strides Pharma Science Ltd is listed on NSE

Is Strides Pharma Science Ltd listed on BSE?

Strides Pharma Science Ltd is listed on BSE

What are today's High and Low prices of Strides Pharma Science Ltd?

  • Today's highest price of Strides Pharma Science Ltd is ₹708.7.
  • Today's lowest price of Strides Pharma Science Ltd is ₹669.

What are today's traded volumes of Strides Pharma Science Ltd?

Today's traded volume of Strides Pharma Science Ltd(STAR) is 7.40L.

What is today's market capitalisation of Strides Pharma Science Ltd?

Today's market capitalisation of Strides Pharma Science Ltd(STAR) is ₹6114.07Cr.

What is the 52 Week High and Low Range of Strides Pharma Science Ltd?

Strides Pharma Science Ltd (STAR)
Price
52 Week High
₹1675
52 Week Low
₹530

How much percentage Strides Pharma Science Ltd is down from its 52 Week High?

Strides Pharma Science Ltd (STAR) share price is ₹688.4. It is down -58.90% from its 52 Week High price of ₹1675

How much percentage Strides Pharma Science Ltd is up from its 52 Week low?

Strides Pharma Science Ltd (STAR) share price is ₹688.4. It is up 29.89% from its 52 Week Low price of ₹530

What are the historical returns of Strides Pharma Science Ltd?

Strides Pharma Science Ltd (STAR)
Returns
1 Day Returns
25%
1 Month Returns
-3.27%
3 Month Returns
-57.5%
1 Year Returns
-4.52%

What is the PE ratio of Strides Pharma Science Ltd today?

PE Ratio of Strides Pharma Science Ltd is 38.57

PE ratio = Strides Pharma Science Ltd Market price per share / Strides Pharma Science Ltd Earnings per share